Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
OSI Systems
OSIS
$3.64B
| $138M | 0.08% |
1,848,229
+13,763
| +0.8% | +$1.01M |
|
252
Gildan
GIL
$9.58B
| $137M | 0.08% |
8,875,000
-1,176,462
| -12% | -$17.4M |
|
253
Electronic Arts
EA
$52.4B
| $137M | 0.08% |
1,037,681
+432,322
| +71% | +$51.1M |
|
254
Workday
WDAY
$39.4B
| $137M | 0.08% |
730,181
+693,308
| +1,880% | +$112M |
|
255
Saia
SAIA
$10.9B
| $137M | 0.08% |
1,230,169
-260,316
| -17% | -$24.9M |
|
|
EQC
256
DELISTED
Equity Commonwealth
EQC
| $136M | 0.08% |
4,216,383
-842,324
| -17% | -$27.8M |
|
257
Union Pacific
UNP
$175B
| $134M | 0.08% |
794,391
-98,006
| -11% | -$15.7M |
|
258
Advanced Micro Devices
AMD
$741B
| $133M | 0.07% |
2,533,451
+855,063
| +51% | +$45.3M |
|
259
Kimberly-Clark
KMB
$37.5B
| $133M | 0.07% |
940,291
+50,690
| +6% | +$7M |
|
260
Kraft Heinz
KHC
$32.4B
| $132M | 0.07% |
4,129,000
+1,525,666
| +59% | +$45.8M |
|
261
RTX Corp
RTX
$295B
| $131M | 0.07% |
2,126,490
-63,769
| -3% | -$3.98M |
|
262
CVS Health
CVS
$140B
| $131M | 0.07% |
2,015,535
+11,354
| +0.6% | +$715K |
|
263
Middleby
MIDD
$6.11B
| $130M | 0.07% |
1,646,780
+9,169
| +0.6% | +$594K |
|
264
Johnson Controls International
JCI
$85.6B
| $130M | 0.07% |
3,806,034
-378,296
| -9% | -$11.6M |
|
|
KYNB
265
Kyntra Bio
KYNB
$28.2M
| $130M | 0.07% |
128,206
+4,967
| +4% | +$4.61M |
|
266
Americold
COLD
$4.17B
| $129M | 0.07% |
3,553,398
-115,196
| -3% | -$3.94M |
|
267
General Mills
GIS
$20.1B
| $129M | 0.07% |
2,085,132
+810,262
| +64% | +$48.9M |
|
268
Travelers Companies
TRV
$82.9B
| $128M | 0.07% |
1,125,846
+322,722
| +40% | +$34M |
|
269
ITT
ITT
$17.8B
| $126M | 0.07% |
2,149,432
-884,580
| -29% | -$46.9M |
|
270
Exelixis
EXEL
$14.2B
| $126M | 0.07% |
5,304,083
+1,689,992
| +47% | +$39.2M |
|
271
Fate Therapeutics
FATE
$270M
| $126M | 0.07% |
3,659,394
+363,775
| +11% | +$10.8M |
|
272
Consolidated Edison
ED
$41.3B
| $123M | 0.07% |
1,710,987
+146,393
| +9% | +$11.2M |
|
273
Manulife Financial
MFC
$74.2B
| $123M | 0.07% |
9,053,617
+1,300,988
| +17% | +$16.4M |
|
|
MXIM
274
DELISTED
Maxim Integrated Products
MXIM
| $122M | 0.07% |
2,014,527
-33,147
| -2% | -$1.85M |
|
275
TransDigm Group
TDG
$73.2B
| $122M | 0.07% |
275,224
-156,217
| -36% | -$59.1M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.